|
Title: |
Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice |
| First author: |
|
| Abstract: |
In an effort to develop novel small molecule PTP1B inhibitors, a series of bromophenol derivatives were designed, synthesized and evaluated in vitro and in vivo. All of the synthesized compounds displayed weak to potent PTP1B inhibitory activities (5.62-9625%) at 20 mu g/mL. Among these compounds, 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol (9) exhibited enhanced PTP1B inhibitory activity (IC50 = 1.50 mu M) than the lead compound BDDPM (IC50 = 2.42 mu M) and high selectivity against other PTPs (TCPTP, LAR, SHP-1 and SHP-2). Results of anti-diabetic assay using C57BL/KsJ-db/db mouse model demonstrated that compound 9 was effective at lowering blood glucose, total cholesterol and HbA1c (P < 0.01). (C) 2013 Elsevier Masson SAS. All rights reserved.
|
| Contact the author: |
|
| Page number: |
|
| Issue: |
|
| Subject: |
|
| Authors units: |
|
| PubYear: |
2013 |
| Volume: |
|
| Unit code: |
133137 |
| Publication name: |
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY |
| The full text link: |
|
| Full papers: |
|
| Departmens of first author: |
|
| Paper source: |
|
| Paper type: |
|
| Participation of the author: |
|
| ISSN: |
|
